Northern Trust
PRQR icon

Northern Trust’s ProQR Therapeutics PRQR Stock Holding History

Northern Trust’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-291,314
Closed -$472K – 4537
2026
Q1 		$472K Sell
291,314
-3,428
-1% -$5.62K ﹤0.01% 3640
2025
Q4 		$595K Hold
294,742
– – ﹤0.01% 3598
2025
Q3 		$628K Sell
294,742
-100,037
-25% -$219K ﹤0.01% 3573
2025
Q2 		$805K Buy
394,779
+3,238
+0.8% +$5.27K ﹤0.01% 3495
2025
Q1 		$521K Sell
391,541
-25,857
-6% -$55K ﹤0.01% 3564
2024
Q4 		$1.11M Buy
417,398
+401,648
+2,550% +$1.28M ﹤0.01% 3349
2024
Q3 		$28.7K Sell
15,750
-182
-1% -$342 ﹤0.01% 4293
2024
Q2 		$26.4K Sell
15,932
-1,488
-9% -$2.89K ﹤0.01% 4303
2024
Q1 		$39.9K Hold
17,420
– – ﹤0.01% 4259
2023
Q4 		$34.5K Hold
17,420
– – ﹤0.01% 4297
2023
Q3 		$22.6K Hold
17,420
– – ﹤0.01% 4312
2023
Q2 		$28.2K Buy
17,420
+6,172
+55% +$12.1K ﹤0.01% 4342
2023
Q1 		$24K Buy
+11,248
New +$34.4K ﹤0.01% 4416
2022
Q1 		– Sell
-6,330
Closed -$51K – 4811
2021
Q4 		$51K Buy
+6,330
New +$48.2K ﹤0.01% 4588
2021
Q3 		– Sell
-13,481
Closed -$91K – 4727
2021
Q2 		$91K Sell
13,481
-4,432
-25% -$28.6K ﹤0.01% 4388
2021
Q1 		$118K Buy
+17,913
New +$91.5K ﹤0.01% 4249
2019
Q4 		– Sell
-38,742
Closed -$223K – 4288
2019
Q3 		$223K Hold
38,742
– – ﹤0.01% 3735
2019
Q2 		$353K Buy
38,742
+4,345
+13% +$51.3K ﹤0.01% 3649
2019
Q1 		$477K Sell
34,397
-7,800
-18% -$116K ﹤0.01% 3551
2018
Q4 		$666K Buy
+42,197
New +$775K ﹤0.01% 3482

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Northern Trust's PRQR Position: Q2 2026 in Review

Northern Trust sold out of ProQR Therapeutics (PRQR) in Q2 2026, closing a stake of 291,314 shares — an estimated $472K sold.

Northern Trust first reported a position in PRQR in Q4 2018 and held it in 20 quarters. The position peaked at $1.11M in Q4 2024. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Northern Trust reported no remaining ProQR Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Northern Trust sold 291,314 ProQR Therapeutics shares in Q2 2026, an estimated $472K.
  • Northern Trust first reported a position in ProQR Therapeutics in Q4 2018 and held it in 20 quarters.
  • Northern Trust's ProQR Therapeutics position peaked at $1.11M in Q4 2024.
  • 70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.